Company overview
Dassault Systèmes provides an integrated digital platform for pharmaceutical and biotech companies spanning research, development, clinical trials, manufacturing, and commercialization. Their solutions leverage 3D visualization, simulation, and AI to accelerate drug development, optimize manufacturing processes, ensure regulatory compliance, and reduce time to market. The company acquired Medidata Solutions to enhance clinical data capabilities and support personalized medicine development.
Dassault Systèmes is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, Software & Digital Lab partner serving United States & Americas. Core focus areas include pharmaceutical manufacturing software, drug development platform, clinical trial management, pharma digital transformation, biotech r&d solutions.
Industry categories: CRO & Clinical Services, Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Dassault Systèmes include Software — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.3ds.com/
- Categories
- CRO & Clinical Services, Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- pharmaceutical manufacturing software, drug development platform, clinical trial management, pharma digital transformation, biotech r&d solutions
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing capabilities does Dassault Systèmes offer for pharma?
- Dassault Systèmes provides Manufacturing Excellence for BioPharma, which delivers digital visibility across the enterprise and data-driven decision-making for therapeutics supply. Their Production Scheduling solution enables agile digital planning, accurate capacity planning, optimized resource allocation, and realistic delivery forecasting at the plant level. These tools help ensure therapies are produced 'As designed' and 'As registered' in a cost-effective manner.
- How does Dassault support pharmaceutical R&D and development?
- Pharmaceutical Development Excellence is a comprehensive platform that integrates virtual and real-world capabilities to streamline development processes and accelerate time to market. The platform addresses challenges including therapeutic complexity, declining R&D productivity, and global competition. Additionally, Dassault's 3DEXPERIENCE platform offers 3D visualization technology to simulate product lifecycles, and their Licensed to Cure for BioPharma tool helps manage drug variation and regulatory compliance.
- What regulatory and compliance support does Dassault provide?
- Dassault Systèmes' solutions are designed to ensure compliance throughout the pharmaceutical lifecycle, from development through manufacturing. Their Licensed to Cure for BioPharma tool specifically aids companies in complying with regulatory requirements. The Manufacturing Excellence platform ensures therapies meet both design and registration standards, supporting companies in meeting stringent regulatory requirements across global markets.
Related editorial coverage
- OCT East Coast: Key Takeaways from Day 1
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
